RecruitingPhase 2NCT05689645

F573 for Injection for the Treatment of Liver Injury/Failure

Studying Acute liver failure

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Continent Pharmaceutical Co, Ltd.
Intervention
F573 for injection(drug)
Enrollment
97 enrolled
Eligibility
18-60 years · All sexes
Timeline
20232026

Study locations (10)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05689645 on ClinicalTrials.gov

Other trials for Acute liver failure

Additional recruiting or active studies for the same condition.

See all trials for Acute liver failure

← Back to all trials